News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Judice Kevin
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/09/2023 |
4
| Judice Kevin (CEO) has filed a Form 4 on DICE Therapeutics, Inc.
Txns:
| Disposed/sold 799,685 shares
@ $0 Disposed/sold 20,464 options to buy
@ $17, valued at
$347.9k
Disposed/sold 16,661 options to buy
@ $17, valued at
$283.2k
Disposed/sold 131,027 options to buy
@ $17, valued at
$2.2M
Disposed/sold 132,074 options to buy
@ $17, valued at
$2.2M
Disposed/sold 384,900 options to buy
@ $19.64, valued at
$7.6M
Disposed/sold 300,000 options to buy
@ $32.31, valued at
$9.7M
Disposed/sold 50,000 restricted stock units
@ $0 |
|
05/05/2023 |
4
| Judice Kevin (CEO) has filed a Form 4 on DICE Therapeutics, Inc.
Txns:
| Sold 13,698 shares
@ $36.5, valued at
$500k
|
|
01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/19/2022 |
4
| Judice Kevin (CEO) has filed a Form 4 on DICE Therapeutics, Inc.
Txns:
| Granted 384,900 options to buy
@ $19.64, valued at
$7.6M
|
|
09/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|